SI0863752T1 - Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases - Google Patents

Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases

Info

Publication number: SI0863752T1
Authority: SI; Slovenia
Prior art keywords: associated diseases; pylori infection; terbinafine; medicament; manufacture
Prior art date: 1995-07-06

Application number

SI9630594T

Other languages

English (en)

Slovenian (sl)

Inventor

Ivan James Dalton Lindley

Neil Stewart Ryder

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-06

Filing date

1996-07-05

Publication date

2003-06-30

1996-07-05 Application filed by Novartis Ag filed Critical Novartis Ag

2003-06-30 Publication of SI0863752T1 publication Critical patent/SI0863752T1/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Emergency Medicine (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)

SI9630594T 1995-07-06 1996-07-05 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases SI0863752T1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9513750.1A GB9513750D0 (en)	1995-07-06	1995-07-06	Use of allylamines
PCT/EP1996/002970 WO1997002026A1 (en)	1995-07-06	1996-07-05	Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
EP96924889A EP0863752B1 (de)	1995-07-06	1996-07-05	Verwendung von allylaminderivaten wie terbinafin zur herstellung eines medikaments zur behandlung von mit einer helicobacter pylori infektion zusammenhängenden erkrankungen

Publications (1)

Publication Number	Publication Date
SI0863752T1 true SI0863752T1 (en)	2003-06-30

Family

ID=10777201

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI9630594T SI0863752T1 (en)	1995-07-06	1996-07-05	Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases

Country Status (27)

Country	Link
US (1)	US5935998A (de)
EP (1)	EP0863752B1 (de)
JP (1)	JP3680950B2 (de)
KR (1)	KR100425401B1 (de)
CN (1)	CN1204881C (de)
AT (1)	ATE232723T1 (de)
AU (1)	AU715270B2 (de)
CA (1)	CA2219678C (de)
CY (1)	CY2465B1 (de)
CZ (1)	CZ289440B6 (de)
DE (1)	DE69626301T2 (de)
DK (1)	DK0863752T3 (de)
ES (1)	ES2192608T3 (de)
GB (1)	GB9513750D0 (de)
HK (1)	HK1011527A1 (de)
HU (1)	HU224311B1 (de)
IL (1)	IL122853A (de)
MX (1)	MX9710093A (de)
MY (1)	MY132436A (de)
NO (1)	NO317496B1 (de)
PL (1)	PL187704B1 (de)
RU (1)	RU2193402C2 (de)
SI (1)	SI0863752T1 (de)
SK (1)	SK282874B6 (de)
TW (1)	TW522011B (de)
WO (1)	WO1997002026A1 (de)
ZA (1)	ZA965749B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0001315D0 (en) *	2000-01-20	2000-03-08	Novartis Ag	Organic compounds
US7244703B2 (en) *	2001-06-22	2007-07-17	Bentley Pharmaceuticals, Inc.	Pharmaceutical compositions and methods for peptide treatment
KR20030066186A (ko) *	2002-02-05	2003-08-09	한솔케미언스 주식회사	(ｅ)-터비나핀 또는 이의 염산염의 제조방법
ES2348303T3 (es)	2003-12-08	2010-12-02	Cpex Pharmaceuticals, Inc.	Composiciones farmacauticas y procedimientos de tratamiento con insulina.
RU2449805C1 (ru)	2011-01-27	2012-05-10	Общество С Ограниченной Ответственностью "Гармония"	Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2716943C2 (de) *	1976-04-28	1986-08-14	Sandoz-Patent-GmbH, 7850 Lörrach	N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
EP0000896B1 (de) *	1977-08-19	1982-10-13	Sandoz Ag	Propenyl-amine, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
DE3020113A1 (de) *	1979-06-08	1980-12-18	Sandoz Ag	2-(1-naphthyl)piperidin-derivat, dessen herstellung sowie die verwendung als antimykotika
US5132459A (en) *	1979-08-22	1992-07-21	Sandoz Ltd.	Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
ATE10272T1 (de) *	1979-08-22	1984-11-15	Sandoz Ag	Propenylamine, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre verwendung als arzneimittel.
US4894375A (en) *	1986-09-29	1990-01-16	Merck & Co., Inc.	Method of controlling mycotic infections and compositions therefor
CA2020888A1 (en) *	1989-07-27	1991-01-28	Philippe Guerry	Substituted aminoalkoxybenzene derivatives
US5200195A (en) *	1991-12-06	1993-04-06	Alza Corporation	Process for improving dosage form delivery kinetics
DE4317449A1 (de) *	1993-05-19	1994-11-24	Asche Ag	Arzneimittel zur Behandlung von Erkrankungen des Magen-Darm-Traktes

1995
- 1995-07-06 GB GBGB9513750.1A patent/GB9513750D0/en active Pending
1996
- 1996-07-05 ES ES96924889T patent/ES2192608T3/es not_active Expired - Lifetime
- 1996-07-05 KR KR10-1998-0700023A patent/KR100425401B1/ko not_active IP Right Cessation
- 1996-07-05 AU AU65195/96A patent/AU715270B2/en not_active Ceased
- 1996-07-05 DK DK96924889T patent/DK0863752T3/da active
- 1996-07-05 RU RU98102187/14A patent/RU2193402C2/ru not_active IP Right Cessation
- 1996-07-05 DE DE69626301T patent/DE69626301T2/de not_active Expired - Lifetime
- 1996-07-05 WO PCT/EP1996/002970 patent/WO1997002026A1/en active IP Right Grant
- 1996-07-05 JP JP50483397A patent/JP3680950B2/ja not_active Expired - Fee Related
- 1996-07-05 EP EP96924889A patent/EP0863752B1/de not_active Expired - Lifetime
- 1996-07-05 PL PL96323305A patent/PL187704B1/pl not_active IP Right Cessation
- 1996-07-05 AT AT96924889T patent/ATE232723T1/de not_active IP Right Cessation
- 1996-07-05 ZA ZA9605749A patent/ZA965749B/xx unknown
- 1996-07-05 SK SK6-98A patent/SK282874B6/sk not_active IP Right Cessation
- 1996-07-05 CA CA002219678A patent/CA2219678C/en not_active Expired - Fee Related
- 1996-07-05 MX MX9710093A patent/MX9710093A/es not_active IP Right Cessation
- 1996-07-05 SI SI9630594T patent/SI0863752T1/xx unknown
- 1996-07-05 US US08/981,324 patent/US5935998A/en not_active Expired - Fee Related
- 1996-07-05 HU HU9802929A patent/HU224311B1/hu not_active IP Right Cessation
- 1996-07-05 IL IL12285396A patent/IL122853A/en not_active IP Right Cessation
- 1996-07-05 CN CNB96195289XA patent/CN1204881C/zh not_active Expired - Fee Related
- 1996-07-05 MY MYPI96002783A patent/MY132436A/en unknown
- 1996-07-05 CZ CZ199817A patent/CZ289440B6/cs not_active IP Right Cessation
- 1996-07-06 TW TW085108161A patent/TW522011B/zh not_active IP Right Cessation
1997
- 1997-12-09 NO NO19975790A patent/NO317496B1/no not_active IP Right Cessation
1998
- 1998-12-07 HK HK98112906A patent/HK1011527A1/xx not_active IP Right Cessation
2004
- 2004-07-02 CY CY0400055A patent/CY2465B1/xx unknown

Also Published As

Publication number	Publication date
CZ289440B6 (cs)	2002-01-16
SK698A3 (en)	1998-05-06
CZ1798A3 (cs)	1998-03-18
IL122853A (en)	2001-04-30
SK282874B6 (sk)	2003-01-09
NO975790D0 (no)	1997-12-09
DK0863752T3 (da)	2003-04-22
EP0863752A1 (de)	1998-09-16
HUP9802929A2 (hu)	1999-09-28
CN1189775A (zh)	1998-08-05
MY132436A (en)	2007-10-31
CA2219678A1 (en)	1997-01-23
IL122853A0 (en)	1998-08-16
US5935998A (en)	1999-08-10
AU715270B2 (en)	2000-01-20
NO317496B1 (no)	2004-11-08
PL187704B1 (pl)	2004-09-30
WO1997002026A1 (en)	1997-01-23
ATE232723T1 (de)	2003-03-15
JPH11508580A (ja)	1999-07-27
GB9513750D0 (en)	1995-09-06
HUP9802929A3 (en)	1999-10-28
DE69626301T2 (de)	2003-10-16
DE69626301D1 (de)	2003-03-27
KR19990028725A (ko)	1999-04-15
PL323305A1 (en)	1998-03-16
KR100425401B1 (ko)	2004-07-16
JP3680950B2 (ja)	2005-08-10
NO975790L (no)	1997-12-09
AU6519596A (en)	1997-02-05
TW522011B (en)	2003-03-01
EP0863752B1 (de)	2003-02-19
CY2465B1 (en)	2005-06-03
MX9710093A (es)	1998-03-31
CA2219678C (en)	2006-10-10
ES2192608T3 (es)	2003-10-16
ZA965749B (en)	1998-01-05
HK1011527A1 (en)	1999-07-16
RU2193402C2 (ru)	2002-11-27
CN1204881C (zh)	2005-06-08
HU224311B1 (hu)	2005-07-28

Publication	Publication Date	Title
NO960067D0 (no)	1996-01-05	Nytt farmasöytisk preparat
DE122010000050I2 (de)	2011-07-21	Sublinguales oder bukkales arzneimittel.
AU684059B2 (en)	1997-12-04	Application of riluzole in the treatment of Parkinson's disease and Parkinsonian syndromes
SE9401728D0 (sv)	1994-05-18	New compounds II
AU2672995A (en)	1995-12-21	{a}-annelated pyrrole derivatives and pharmaceutical uses thereof
HK1011527A1 (en)	1999-07-16	Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
NZ268110A (en)	1999-06-29	Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage
CZ176395A3 (en)	1995-12-13	The use of riluzol for preparing medicaments acceptable as antidotes against harmful effects of irradiation
AU2796695A (en)	1996-01-15	Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders